NCT04649801View on ClinicalTrials.gov

Catheter Ablation for Atrial Fibrillation in patientS With End-sTage Heart Failure and Eligibility for Heart Transplantation

NACompletedINTERVENTIONAL

Enrollment

194

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

May 15, 2023

Conditions

Heart FailureAtrial Fibrillation

Interventions

PROCEDURE

Atrial fibrillation ablation

Catheter ablation

Trial Locations (1)

32545

Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen

All Listed Sponsors

lead

Heart and Diabetes Center North-Rhine Westfalia

OTHER

NCT04649801 - Catheter Ablation for Atrial Fibrillation in patientS With End-sTage Heart Failure and Eligibility for Heart Transplantation | Biotech Hunter | Biotech Hunter